IP Library Patent Application 16889779
Patent Application
App. No. 16/889,779

SYSTEMS AND METHODS OF CLINICAL TRIAL EVALUATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/889,779
Abstract

Systems and methods are configured to match a patient to a clinical trial. A method includes receiving text-based criteria for the clinical trial, including a molecular marker. Additionally, the method includes associating at least a portion of the text-based criteria to one or more pre-defined data fields containing molecular marker information. The method further includes comparing a molecular marker of the patient to the one or more pre-defined data fields, and generating a report for a provider. The report is based on the comparison and includes a match indication of the patient to the clinical trial.

Claims (46)

1 . A method of matching a patient to a clinical trial, the method comprising:

receiving text-based criteria for the clinical trial, including a molecular marker;

associating at least a portion of the text-based criteria to one or more pre-defined data fields containing molecular marker information;

comparing a molecular marker of the patient to the one or more pre-defined data fields; and

generating a report for a provider, the report based on the comparison and including a match indication of the patient to the clinical trial.

2 . The method of claim 1 , wherein the molecular marker is an RNA sequence.

3 . The method of claim 1 , wherein the molecular marker is a DNA sequence.

4 . The method of claim 1 , wherein the one or more pre-defined data fields include inclusion criteria and exclusion criteria.

5 . The method of claim 1 further comprising:

determining that the patient has not received a treatment related to the molecular marker of the patient; and

determining that the patient is eligible for at least one candidate clinical trial in response to determining that the patient has not received the treatment.

6 . The method of claim 1 , wherein at least a portion of the text based criteria is free-text.

7 . A clinical trial matching system comprising at least one processor and at least one memory, the system configured to:

receive text-based criteria for a clinical trial, including a molecular marker;

associate at least a portion of the text-based criteria to one or more pre-defined data fields containing molecular marker information;

compare a molecular marker of a patient to the one or more pre-defined data fields; and

generate a report for a provider, the report based on the comparison and including a match indication of the patient to the clinical trial.

8 . The system of claim 7 , wherein the molecular marker is an RNA sequence.

9 . The system of claim 7 , wherein the molecular marker is a DNA sequence.

10 . The system of claim 7 , wherein the one or more pre-defined data fields include inclusion criteria and exclusion criteria.

11 . The system of claim 7 , wherein the system is further configured to:

determine that the patient has not received a treatment related to the molecular marker of the patient; and

determine that the patient is eligible for at least one candidate clinical trial in response to determining that the patient has not received the treatment.

12 . The system of claim 7 , wherein at least a portion of the text based criteria is free-text.

13 . A method of matching a patient to a clinical trial, the method comprising:

receiving health information from an electronic medical record corresponding to the patient;

determining data elements within the health information using at least one of an optical character recognition (OCR) method and a natural language processing (NLP) method;

comparing the data elements to pre-determined trial criteria, including trial inclusion criteria and trial exclusion criteria;

determining at least one matching clinical trial, based on the comparing of the data elements to the predetermined trial criteria; and

notifying a practitioner associated with the patient of the at least one matching clinical trial.

14 . The method of claim 13 , wherein the pre-determined trial criteria is generated based on unstructured text.

15 . The method of claim 13 , wherein the pre-determined trial criteria is formatted in at least one standardized format in use by a medical institution.

16 . The method of claim 13 , wherein the data elements include at least one of a clinical feature, a molecular feature, an epigenome feature, a microbiome feature, an organoid feature, or an imaging feature.

17 . The method of claim 13 further comprising periodically updating a clinical trial database comprising the at least one matching clinical trial and at least one non-matching trial.

18 . The method of claim 13 , wherein notifying the practitioner associated with the patient of the at least one matching clinical trial comprises causing a report to be displayed to the practitioner, the report comprising the locations of the at least one matching trial.

19 . A clinical trial matching system comprising at least one processor and at least one memory, the system configured to:

receive health information from an electronic medical record corresponding to the patient;

determine data elements within the health information using at least one of an optical character recognition (OCR) method and a natural language processing (NLP) method;

compare the data elements to pre-determined trial criteria, including trial inclusion criteria and trial exclusion criteria;

determine at least one matching clinical trial, based on the comparing of the data elements to the predetermined trial criteria; and

notify a practitioner associated with the patient of the at least one matching clinical trial.

20 . The system of claim 19 , wherein the pre-determined trial criteria is generated based on unstructured text.

21 . The system of claim 19 , wherein the pre-determined trial criteria is formatted in at least one standardized format in use by a medical institution.

22 . The system of claim 19 , wherein the data elements include at least one of a clinical feature, a molecular feature, an epigenome feature, a microbiome feature, an organoid feature, or an imaging feature.

23 . The system of claim 19 , wherein the system is further configured to periodically update a clinical trial database comprising the at least one matching clinical trial and at least one non-matching trial.

24 . The system of claim 19 , wherein notifying the practitioner associated with the patient of the at least one matching clinical trial comprises causing a report to be displayed to the practitioner, the report comprising the locations of the at least one matching trial.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded May 13, 2026
From: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
To: TEMPUS AI, INC. (F/K/A TEMPUS LABS, INC.)
Reel/Frame 075608/0784 →
CHANGE OF NAME Recorded Feb 9, 2024
From: TEMPUS LABS, INC.
To: TEMPUS AI, INC.
Reel/Frame 066544/0110 →
SECURITY INTEREST Recorded Sep 22, 2022
From: TEMPUS LABS, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 061506/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2021
From: OZERAN, JONATHAN; TAVA, CHRISTOPHER PAUL; FRANZEN, AMY GORDON; RITT, KEVIN; ACKERMANN, MARC
To: TEMPUS LABS
Reel/Frame 054848/0181 →